# SIROLIMUS
> **ANDA216728** · Abbreviated New Drug Application (Generic) · Sponsor: MSN · Approved 2023-01-19
## Drug
- **FDA Application Number:** ANDA216728
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** SIROLIMUS
- **Generic name:** SIROLIMUS
- **Active ingredients:** SIROLIMUS
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSN
- **Manufacturer:** Northstar Rx LLC
- **First approval:** 2023-01-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216728)
---
*AI Analytics · CC0 1.0*